Literature DB >> 8824296

Beta1,4-N-acetylgalactosaminyltransferase (GM2 synthase) is released from Golgi membranes as a neuraminidase-sensitive, disulfide-bonded dimer by a cathepsin D-like protease.

E Jaskiewicz1, G Zhu, R Bassi, D S Darling, W W Young.   

Abstract

Many Golgi membrane-bound glycosyltransferases are released from cells in a soluble form. To characterize this release process, we stably transfected Chinese hamster ovary cells with three myc epitope-tagged forms of cloned beta1, 4-N-acetylgalactosaminyltransferase (GalNAcT); two of these forms resided in the Golgi, while the third was retained in the ER. GalNAcT was released into the culture medium from cells transfected with the Golgi forms but not with the ER form of the enzyme. The medium from cells transfected with the Golgi forms contained disulfide-bonded dimers of GalNAcT, which carried neuraminidase sensitive, complex N-linked carbohydrate chains. This soluble species represented the major degradation product of cellular GalNAcT, which turned over with a half-time of about 1.7 h. The soluble species consisted of a mixture of truncated GalNAcT molecules, the major form of which was produced by cleavage near the boundary between the transmembrane and lumenal domains between Leu-23 and Tyr-24. This cleavage site fits the sequence pattern for sites cleaved by cathepsin D (van Noort, J.M., and van der Drift, A. C.M. (1989) J. Biol. Chem. 264, 14159-14164). These findings suggest that GalNAcT is converted from a membrane-bound to a soluble form as a result of cleavage by a cathepsin D-like protease in a compartment late in the Golgi secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons.

Authors:  C A Stern; M Tiemeyer
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 2.  Organization of Golgi glycosyltransferases in membranes: complexity via complexes.

Authors:  W W Young
Journal:  J Membr Biol       Date:  2004-03-01       Impact factor: 1.843

3.  Specificity of Processing α-glucosidase I is guided by the substrate conformation: crystallographic and in silico studies.

Authors:  Megan K Barker; David R Rose
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

Review 4.  Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells.

Authors:  E Grabenhorst; P Schlenke; S Pohl; M Nimtz; H S Conradt
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

5.  GDP-fucose uptake into the Golgi apparatus during xyloglucan biosynthesis requires the activity of a transporter-like protein other than the UDP-glucose transporter.

Authors:  C Wulff; L Norambuena; A Orellana
Journal:  Plant Physiol       Date:  2000-03       Impact factor: 8.340

6.  Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases.

Authors:  C A Wiggins; S Munro
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  Reevaluating the effect of Brefeldin A (BFA) on ganglioside synthesis: the location of GM2 synthase cannot be deduced from the inhibition of GM2 synthesis by BFA.

Authors:  W W Young; M L Allende; E Jaskiewicz
Journal:  Glycobiology       Date:  1999-07       Impact factor: 4.313

8.  Glycoproteomic and Phenotypic Elucidation of B4GALNT2 Expression Variants in the SID Histo-Blood Group System.

Authors:  Linn Stenfelt; Jonas Nilsson; Åsa Hellberg; Yew Wah Liew; Jenny Morrison; Göran Larson; Martin L Olsson
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

9.  Robust, Durable Gene Activation In Vivo via mRNA-Encoded Activators.

Authors:  Jared P Beyersdorf; Swapnil Bawage; Nahid Iglesias; Hannah E Peck; Ryan A Hobbs; Jay A Wroe; Chiara Zurla; Charles A Gersbach; Philip J Santangelo
Journal:  ACS Nano       Date:  2022-03-31       Impact factor: 18.027

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.